Literature DB >> 11517648

Management of congestive heart failure: how well are we doing?

N Giannetti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11517648      PMCID： PMC81332     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study.

Authors:  M Echemann; F Zannad; S Briançon; Y Juillière; P M Mertès; J M Virion; J P Villemot
Journal:  Am Heart J       Date:  2000-04       Impact factor: 4.749

2.  Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals.

Authors:  E F Philbin; C Andreaou; T A Rocco; L J Lynch; S L Baker
Journal:  Am J Cardiol       Date:  1996-04-15       Impact factor: 2.778

3.  Variations in family physicians' and cardiologists' care for patients with heart failure.

Authors:  D W Baker; R P Hayes; B M Massie; C A Craig
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

4.  Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

Authors:  M Packer; P A Poole-Wilson; P W Armstrong; J G Cleland; J D Horowitz; B M Massie; L Rydén; K Thygesen; B F Uretsky
Journal:  Circulation       Date:  1999-12-07       Impact factor: 29.690

5.  Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study.

Authors:  W A Gattis; V Hasselblad; D J Whellan; C M O'Connor
Journal:  Arch Intern Med       Date:  1999-09-13

6.  Quality of care for patients hospitalized with heart failure at academic medical centers.

Authors:  A Nohria; Y T Chen; D J Morton; R Walsh; P H Vlasses; H M Krumholz
Journal:  Am Heart J       Date:  1999-06       Impact factor: 4.749

7.  Quality of congestive heart failure treatment at a Canadian teaching hospital.

Authors:  E Weil; J V Tu
Journal:  CMAJ       Date:  2001-08-07       Impact factor: 8.262

8.  Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.

Authors:  B M Massie; P W Armstrong; J G Cleland; J D Horowitz; M Packer; P A Poole-Wilson; L Rydén
Journal:  Arch Intern Med       Date:  2001-01-22

9.  Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome.

Authors:  R Belardinelli; D Georgiou; G Cianci; A Purcaro
Journal:  Circulation       Date:  1999-03-09       Impact factor: 29.690

10.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.